Mismatch repair-proficient (PMMR) rectal cancer

Clinical trials for Mismatch repair-proficient (PMMR) rectal cancer explained in plain language.

Never miss a new study

Get alerted when new Mismatch repair-proficient (PMMR) rectal cancer trials appear

Sign up with your email to follow new studies for Mismatch repair-proficient (PMMR) rectal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New triple therapy aims to shrink rectal tumors and avoid surgery

Disease control Not yet recruiting

This phase 2 trial tests a new approach for people with locally advanced rectal cancer that is not responding well to standard immunotherapy. Participants will receive short-course radiation, followed by an experimental drug (QL1706) that boosts the immune system, plus chemothera…

Matched conditions: MISMATCH REPAIR-PROFICIENT (PMMR) RECTAL CANCER

Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 26, 2026 18:06 UTC

Mismatch repair-proficient (PMMR) rectal cancer

Get alerted when new Mismatch repair-proficient (PMMR) rectal cancer trials appear

New triple therapy aims to shrink rectal tumors and avoid surgery